ResourceDrug Discovery & Development
From preclinical insight to clinical proof, one continuum
20 Oct 2026This product brochure outlines Evotec's integrated clinical development services designed to streamline the transition from preclinical research through Phase I and early Phase II studies. Discover how clinical operations, regulatory affairs, pharmacometrics, translational medicine, bioanalysis, immunoassays and ADME expertise are combined within a single development framework to reduce delays and support informed decision-making. Explore capabilities including First-in-Human studies, biomarker strategies, model-informed drug development, regulatory submissions and real-time data workflows that help accelerate early clinical programs and de-risk drug development.
Resource details:
Resource type: Product brochure
Page count: 4
Read time: 6 mins
Links
Tags
Clinical TrialsClinical Trials, an essential part of drug discovery process, assess the safety and effectiveness of a new medication or device in the pharmaceutical industry. Clinical Trials are a phased process (Phase 0, Phase I, Phase II, Phase III and Phase IV) which begins after initial preclinical testing.ADME-ToxicologyADME-toxicology (ADME-Tox) studies are used in pharmacology and pharmacokinetics to assess the activity/toxicity of drugs <i>in vivo</i> or <i>in vitro</i>. Find bioassays for absorption, distribution, metabolism, and excretion of drug molecules including cytotoxicity, transporter/permeability, metabolism and activity assays as well as hepatocytes and cell lines for ADME. Find the best ADME-toxicology products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.BiomarkersBiomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :